CYTOSAR 100MG INJECTION contains Cytarabine which belongs to the group of medicines called Anticancer agents. It is used for certain types of blood cancer and lymph cancer (Ex. acute myeloid leukemia, erythroleukemia, meningeal leukemia, acute non-lymphoblastic/lymphoblastic leukemia, acute lymphocytic leukemia, chronic myeloid leukemia, non-Hodgkin’s lymphoma).
Before receiving CYTOSAR 100MG INJECTION, inform your doctor if you have any liver or kidney problems. You must also inform your doctor if you have low RBC, WBC and platelet counts in blood, or currently taking radiotherapy as a precaution. Avoid consumption of alcohol while undergoing therapy with this medicine. CYTOSAR 100MG INJECTION is not recommended for use in pregnant or breastfeeding women. Both men and women of childbearing potential must use a suitable contraceptive to avoid pregnancy while undergoing therapy with this medicine and until 6 months after the last dose.
The most common side effects of receiving CYTOSAR 100MG INJECTION are low RBC, WBC and platelet counts leading to anemia, increased infections and bleeding tendency and loss of appetite, abnormal eye movements, eye pain, redness and inflammation, nausea, vomiting, mouth ulcers, sore tongue, skin rashes, hair loss and inflammation at the injection site. Consult your doctor if any of these above side effect worsens.
No content available
